Products
FDA Launches Expedited IND Pilot, Begins Accepting Applications
Summary: The U.S. Food and Drug Administration today announced the final design of the Expedited Investigational New Drug (IND) Pilot.
The U.S. Food and Drug Administration today announced the final design of the Expedited Investigational New Drug (IND) Pilot.
Adults 21+. WINDBAR does not sell nicotine products on this site. Compliance statement.
